stella
beta
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care — Stella
Home
/
NSCLC
/
View on ClinicalTrials.gov
Recruiting
Back to NSCLC trials
Trial locations
(1 site)
United States
Dana-Farber Cancer Institute, Boston, Massachusetts